Bluejay Diagnostics, Inc.

General ticker "BJDX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $6.5M (TTM average)

Bluejay Diagnostics, Inc. does not follow the US Stock Market performance with the rate: -30.7%.

Estimated limits based on current volatility of 8.6%: low 1.68$, high 1.99$

Factors to consider:

  • Earnings expected soon, date: 2025-05-21 bmo
  • Current price 32.6% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.55$, 10.78$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.26$, 10.80$]

Financial Metrics affecting the BJDX estimates:

  • Negative: Non-GAAP EPS, $ of -759.99 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -91.17 <= 1.79
  • Negative: Industry operating cash flow per share per price (median), % of -3.23 <= 2.82
  • Negative: Interest expense per share, $ of 4.49 > 0.67
  • Positive: Industry inventory ratio change (median), % of -0.37 <= -0.28
  • Negative: negative Industry operating income (median)
  • Negative: Shareholder equity ratio, % of 86.06 > 63.75

Similar symbols

Short-term BJDX quotes

2025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-0712345678910
Price $

Long-term BJDX plot with estimates

05001000150020002500300035004000Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−400−300−200−1000
BJDXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.25MM $0.00MM $0.00MM
Operating Expenses $9.57MM $10.31MM $7.17MM
Operating Income $-9.32MM $-10.31MM $-7.17MM
Non-Operating Income $0.02MM $0.36MM $-0.55MM
Interest Expense $0.00MM $0.00MM $0.82MM
R&D Expense $4.15MM $5.71MM $3.47MM
Income(Loss) $-9.30MM $-9.95MM $-7.72MM
Profit(Loss)* $-9.23MM $-9.95MM $-7.72MM
Stockholders Equity $11.54MM $2.89MM $5.73MM
Assets $13.52MM $4.87MM $6.66MM
Operating Cash Flow $-7.74MM $-8.31MM $-7.82MM
Capital expenditure $1.20MM $0.70MM $0.31MM
Investing Cash Flow $-1.20MM $-0.70MM $-0.31MM
Financing Cash Flow $0.01MM $1.11MM $10.22MM
Earnings Per Share** $-73.22 $-72.62 $-42.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.